S2Medical AB
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more
S2Medical AB (S2M) - Total Liabilities
Latest total liabilities as of June 2025: Skr7.08 Million SEK
Based on the latest financial reports, S2Medical AB (S2M) has total liabilities worth Skr7.08 Million SEK as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
S2Medical AB - Total Liabilities Trend (2015–2025)
This chart illustrates how S2Medical AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
S2Medical AB Competitors by Total Liabilities
The table below lists competitors of S2Medical AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AMADEUS IT HOLD -A-
BE:AI3A
|
Germany | €6.74 Billion |
|
Wisconsin Electric Power Company PFD 3.60%
OTCQB:WELPP
|
USA | $11.06 Billion |
|
NEW YORK TIMES -A- - Dusseldorf Stock Exchang
DU:NYT
|
Germany | €910.05 Million |
|
Bitcoin Fund Unit
TO:QBTC
|
Canada | CA$1.09 Million |
|
TRIMBLE NAVIGATION
BE:TB5
|
Germany | €5.04 Billion |
|
Twin Vee Powercats Co
NASDAQ:VEEE
|
USA | $2.96 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down S2Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how S2Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for S2Medical AB (2015–2025)
The table below shows the annual total liabilities of S2Medical AB from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr6.90 Million | +9.73% |
| 2024-12-31 | Skr6.29 Million | -68.17% |
| 2023-12-31 | Skr19.75 Million | +8.36% |
| 2022-12-31 | Skr18.22 Million | +21.54% |
| 2021-12-31 | Skr15.00 Million | +76.90% |
| 2020-12-31 | Skr8.48 Million | +51.40% |
| 2019-12-31 | Skr5.60 Million | +1.21% |
| 2018-12-31 | Skr5.53 Million | +45.66% |
| 2017-12-31 | Skr3.80 Million | +3.35% |
| 2016-12-31 | Skr3.67 Million | +6.24% |
| 2015-12-31 | Skr3.46 Million | -- |